Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Autolus Therapeutics (AUTL) Times Interest Earned: 2021-2025

Historic Times Interest Earned for Autolus Therapeutics (AUTL) over the last 4 years, with Sep 2025 value amounting to -$6.81.

  • Autolus Therapeutics' Times Interest Earned fell 7.18% to -$6.81 in Q3 2025 from the same period last year, while for Sep 2025 it was $16.11, marking a year-over-year increase of 617.32%. This contributed to the annual value of -$25.98 for FY2024, which is 551.46% down from last year.
  • Autolus Therapeutics' Times Interest Earned amounted to -$6.81 in Q3 2025, which was down 175.95% from $8.96 recorded in Q2 2025.
  • Autolus Therapeutics' 5-year Times Interest Earned high stood at $8.96 for Q2 2025, and its period low was -$21.58 during Q2 2022.
  • Over the past 3 years, Autolus Therapeutics' median Times Interest Earned value was -$6.35 (recorded in 2024), while the average stood at -$3.92.
  • The largest annual percentage gain for Autolus Therapeutics' Times Interest Earned in the last 5 years was 254.77% (2025), contrasted with its biggest fall of 219.78% (2025).
  • Over the past 5 years, Autolus Therapeutics' Times Interest Earned (Quarterly) stood at -$20.85 in 2021, then surged by 83.84% to -$3.37 in 2022, then skyrocketed by 47.53% to -$1.77 in 2023, then soared by 239.15% to $2.46 in 2024, then dropped by 7.18% to -$6.81 in 2025.
  • Its Times Interest Earned stands at -$6.81 for Q3 2025, versus $8.96 for Q2 2025 and -$6.43 for Q1 2025.